Ambelvist 0.1 mmol/ nl, Injektionslösung in einer Fertigspritze

7680704400011 CH-70440 Injektionslösung

Associated product:

AMBELVIST 0.1 mmol/ nl sol inj ser préremp 257.9 m

No image available

Article details

Package size
7.5
Selling units
7
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
gadoquatranum
257.9 MG Substance Wirkstoff (Principe actif)
gadolinium
62.9 MG Substance WIIS
calcobutrolum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
trometamolum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.235 MG Substance HBESI

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
70440
Drug name
Ambelvist, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
V08CA13
Authorization status
Z
Dispensing category
B
First authorization
28/08/2026
Authorization expiration date
27/08/2031
IT Number
14.02.0.
Domain
Human medicine
Field of application
MRT-Kontrastmittel für die ZNS-Diagnostik und weitere Körperregionen

Package details

Description (FR)
AMBELVIST 0.1 mmol/ nl sol inj ser préremp 257.9 m
Description (DE)
AMBELVIST 0.1 mmol/ nl Inj Lös Fertspr 257.9 mg 7.
Market launch
01/11/2026
Narcotic (BTM)
No

Other package sizes (2)

AMBELVIST 0.1 mmol/ nl sol inj ser préremp 257.9 m
10 ML
GTIN: 7680704400028
View
None
15 ML
GTIN: None
Not in V1
Buy us a coffee Explore the data